Rare diseases
Investigational molecules
Locations
Back to Italy142 clinical trials in Alexandria, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
ItalyStudy on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
ItalyA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
ItalyStudy on the Effects of Tigulixostat and Allopurinol in Patients with Gout and High Uric Acid Levels
ItalyStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
ItalyDurvalumab versus standard chemotherapy drug combination in elderly patients with advanced non‑small cell lung cancer
ItalyPhase 3 Study of INCB123667 versus investigator's choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression
ItalyA study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis
ItalyA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
ItalyStudy on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis
ItalyStudy Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments
ItalyStudy on Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Transplant
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on blood cancers and related disorders, including studies on innovative treatments for lymphoma, leukemia, and multiple myeloma. Clinical trials are evaluating novel therapeutic combinations and targeted approaches.
Investigations include immunotherapy combinations and maintenance strategies for improved patient outcomes.
Studies focusing on preventing and treating respiratory infections and conditions, with particular emphasis on vulnerable populations. Research includes vaccine development and therapeutic interventions.
Trials are exploring novel treatments and preventive strategies for respiratory conditions.
Important studies in heart failure prevention and treatment, investigating new therapeutic combinations and strategies to reduce cardiovascular risks in high-risk populations.
Research focuses on innovative drug combinations to prevent heart failure events and improve outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
